definiens: is hereby amended as follows : shall mean any pharmaceutical p roduct containing an Anti - KIR Antibody ( alone or with any other pharmaceutically active ingredient ), in all forms, presentations, formulations and dosa ge forms . ” 5 . Notwithstanding anything in Section 5.5 of the Agre ement to the contrary but subject to amendments mad e applicable to Section 5.5 in Sections 3.1.1 and 3.1 .2 of Amendment No . 1, IPH obtained a grant ( or gra nt back, as the case may be ) from NN of an exclusive r ight and license, including the right to Sub - licens e and Out - license, throughout the Territory during the Te rm, under ( a ) all Intellectual Property Rights lice nsed exclusively to NN pursuant to Section 5.1, and ( b ) all Background NN IPR and Collaboration IPR Controlled by NN, to the extent that such rights an d licenses are necessary or useful to conduct resea rch with and of, discover, develop, use, manufacture, h ave manufactured, register, package, sample, distri bute, promote, market, offer for sale, import, export, se ll and have sold Anti - KIR Antibodies and/or Anti - KI R Products for all uses and purposes